Trial Profile
Effect of quercetin on atherosclerosis risk factors, inflammation biomarkers and oxidative stress, based on the apolipoprotein E (APOE) genotype.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Quercetin (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 03 Dec 2015 New trial record